TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
QIAGEN DNA Synthesis AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 78,460 | 85,547 | 130,196 |
Financial expenses | 4,961 | 2,434 | 1,617 |
Earnings before taxes | -53,200 | -32,499 | -7,423 |
EBITDA | -40,223 | -22,804 | -1,841 |
Total assets | 159,529 | 142,408 | 149,291 |
Current assets | 89,847 | 74,058 | 76,523 |
Current liabilities | 140,555 | 130,234 | 101,835 |
Equity capital | 18,974 | 12,174 | 47,456 |
- share capital | 200 | 200 | 200 |
Employees (average) | 105 | 97 | 91 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 11.9% | 8.5% | 31.8% |
Turnover per employee | 747 | 882 | 1,431 |
Profit as a percentage of turnover | -67.8% | -38.0% | -5.7% |
Return on assets (ROA) | -30.2% | -21.1% | -3.9% |
Current ratio | 63.9% | 56.9% | 75.1% |
Return on equity (ROE) | -280.4% | -267.0% | -15.6% |
Change turnover | -7,087 | -44,649 | 45,639 |
Change turnover % | -8% | -34% | 54% |
Chg. No. of employees | 8 | 6 | 19 |
Chg. No. of employees % | 8% | 7% | 26% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.